Dermatofibrosarcoma protuberans

International Journal of Dermatology

Volumn 35, Issue 12, 1996, Pages 867-871

  Garcia, Carlos ^a   Clark, Robert E ^a   Buchanan, Mark ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOSURGERY; CLINICAL ARTICLE; FEMALE; HISTIOCYTOMA; HUMAN; HUMAN TISSUE; MALE;

EID: 0030455137     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb05053.x     Document Type: Article

References (26)

1. Laskin WB. Dermatofibrosarcoma protuberans. CA Cancer Journal for Clinicians 1992; 42:116-125.
2. Gutierrez G, Ospina J, De Baez NE, et al. Dermatofibrosarcoma protuberans. Int J Dermatol 1984; 23:396-401.
3. Mark RJ, Bailet JW, Tran LM, et al. Dermatofibrosarcoma protuberans of the head and neck. A report of 16 cases. Arch Otolaryngol Head Neck Surg 1993; 119: 891-896.
4. Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol 1994; 21:324-329.
5. Bendix-Hansen K, Myhre-Jensen O, Kaae S. Dermatofibrosarcoma protuberans. A clinical pathological study of 19 cases and review of the world literature. Scand J Plast Reconstruct Surg 1983; 17:247-252.
6. From L, Dalal A. Neoplasms, pseudoneoplasms, and hyperplasia of supporting tissue origins. In: Fitzpatrick TD, Eisen AZ, Wolff K, et al. Dermatology in general medicine. 4th Ed. New York: McGraw Hill, 1993:1203-1204.
7. Andrew JE, Silvers DN, Lattes R. Sarcomas involving the skin and superficial tissues. In: Friedman RJ, Rigel DS, Kopf AW, et al., eds. Cancer of the skin. Philadelphia: WB Saunders, 1991:263-287.
8. Lopes JM, Paiva ME. Dermatofibrosarcoma protuberans: a histological and ultrastructural study of 11 cases with emphasis on the study of recurrences and histogenesis. Path Res Pract 1991; 187:806-813.
9. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans: a clinical pathologic review with emphasis on sarcomatous areas. Am J Surg Pathol 1992; 16:91-95.
10. Zeiger B, Sidoroff A, Stanzl U, et al. Deep penetrating dermatofibroma vs. dermatofibrosarcoma protuberans. A clinicopathologic comparison. Am J Surg Pathol 1994; 18:677-686.
11. Cohen PR, Rapini RP, Farhood AI. Expression of the human hematopoietic progenitor cell antigen CD34 in dermatofibrosarcoma protuberans, other spindle cell tumors, and vascular lesions. J Am Acad Dermatol 1994; 30:147. (Letter)
12. Altman DA, Nickoloff BJ, Fivenson DP. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. J Cutan Pathol 1993; 20:154-158.
13. Aiba S, Pavata N, Ishii H, et al. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumor expressing CD34. Br J Dermatol 1992; 127:79-84.
14. Cohen PR, Rapini RP, Farhood AI. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cells tumor. J Cutan Pathol 1993; 20:15-20.
15. Abenoza P, Lillemo T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993; 15:429-434.
16. Kudzner H. Expression of the human progenitor cell antigen CD34 distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed paraffin-embedded tissue. J Am Acad Dermatol 1993; 28:613-617.
17. Smola MG, Soyer HE, Scharnagl E. Surgical treatment of DFSP. Retrospective study of 20 cases with review of literature. Eur J Surg Oncol 1991; 17:447-453.
18. Clark DP. Management of uncommon malignant tumors. In: Wheeland RG, ed. Cutaneous surgery. Philadelphia: WB Saunders, 1994:816-818.
19. Brown MD, Swanson NA. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthoma with Mohs micrographic surgery. J Dermatol Surg Oncol 1989; 15:1287-1292.
20. Robinson JK. Dermatofibrosarcoma protuberans resected by Mohs surgery. A 5-year prospective study. J Am Acad Dermatol 1985; 12:1093-1098.
21. Hanke WC, Lee NW. Treatment of rare malignancies. In: Mikhail GR, ed. Mohs micrographic surgery. Philadelphia: WB Saunders, 1991:261-274.
22. Hashimoto K, Fujawara K, Mehregan A. Current topics in immunohistochemistry as applied to skin tumors. J Dermatol 1993; 20:521-532.
23. Kamino H, Burchette J, Garcia JA. Immunostaining for CD34 in plaque and nodular areas of dermatofibrosarcoma protuberans. J Cutan Pathol 1992 19:530. [Abstr]
24. Rabinowitz LG, Luchetti ME, Segura AD, Easterly NB. Acrally occurring dermatofibrosarcoma protuberans in children and adults. J Dermatol Surg Oncol 1994; 20: 655-659.
25. Hobbs ER, Wheeland RG, Bailin PL, et al. Treatment of dermatofibrosarcoma protuberans with Mohs micrographic surgery. Ann Surg 1988; 207:102-107.
26. Rutgers DJ, Kroon BB, Albus-Lutter CH, Gortzak E. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol 1992; 18:241-248.